Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Translational Oncology|September 7, 2025
Clinical applications of cell-free DNA-based liquid biopsy analysisShu Yazaki, Momoko Tokura, Hisaki Aiba, et al.
JCO Precision Oncology|June 26, 2025
AlphaMissense for Identifying Pathogenic Missense Mutations in DNA Damage Repair Genes in CancerShu Yazaki, Xin Pei, Simon Powell, et al.
Anti-Cancer Drugs|September 2, 2020
Lower response to trastuzumab emtansine in metastatic breast cancer patients with human epidermal growth factor receptor 2 immunohistochemistry score of 2 and fluorescence in situ hybridization positive compared with immunohistochemistry score of 3: a retrospective studyShu Yazaki, Jun Hashimoto, Shin Ogita, et al.
Gynecologic Oncology|July 28, 2023
Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcomaAyumi Saito, Tadaaki Nishikawa, Hiroshi Yoshida, et al.
Medicine|September 22, 2020
Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatmentRurina Watanuki, Akihiko Shimomura, Shu Yazaki, et al.
BMC Cancer|January 14, 2022
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective studyShigemasa Takamizawa, Tatsunori Shimoi, Natsuko Satomi-Tsushita, et al.
International Journal of Clinical Oncology|February 21, 2024
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational studyYuki Katsuya, Tatsuya Yoshida, Atsuo Takashima, et al.
Japanese Journal of Clinical Oncology|April 24, 2023
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcomaHisaki Aiba, Yuki Kojima, Tatsunori Shimoi, et al.
Cancer Medicine|March 11, 2024
Incidence of skeletal-related events in patients with Ewing sarcoma: An observational retrospective study in JapanHisaki Aiba, Yuki Kojima, Tatsunori Shimoi, et al.
BMC Cancer|April 15, 2022
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective studyShigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, et al.
Pageof 4